GLOBAL SACRAL NERVE STIMULATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Market News

Global Sacral Nerve Stimulation Market - Recent Developments

Product and Technology Launch

• In February 22, 2022, Medtronic plc, a global in healthcare technology company, announced that it received approval from the U.S. Food and Drug Administration (FDA) for InterStim X ― the next generation of the InterStim portfolio's recharge-free device – and it is available immediately. Moreover, InterStim systems are the standard of care in advanced therapy options, and the most personalized system, to deliver sacral neuromodulation (SNM) therapy.
• In January 31, 2023, Axonics, Inc. a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that the U.S. Food and Drug Administration has approved the company's fourth-generation rechargeable sacral neuromodulation system.

Business Development Activities by the Market Players

In April 2023, Axonics, Inc.,a global medical technology company that develops and commercialize novel products for the treatment of bladder and bowel dysfunction, announced the acquisition of a lead placement solution from Radian, LLC. that complements Axonics Inc.s' existing sacral neuromodulation (SNM) offering.